Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tyler Autera
AddedMar 31, 2024
UpdatedMay 31, 2026
Tyler Autera

Tyler Autera

Co-Founder, Bluestem Biosciences

CrunchbaseLinkedIn

Tyler Autera's Career

Bluestem Biosciences
Bluestem Biosciences

Omaha, NE, US

Co-Founder
Cannalysis
Cannalysis

Santa Ana, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tyler Autera's Career

Bluestem Biosciences
Bluestem Biosciences
Pre-Seed$10M82022Omaha, NE, US
Co-Founder

Leadership at Bluestem Biosciences

Jared WengerJared WengerCo-Founder
Billy HagstromBilly HagstromCEO

Similar to Bluestem Biosciences

Think BioscienceThink BioscienceBoulder, CO, USMedicinesest. 2019Think BioscienceBoulder, CO, US · est. 2019

Think Bioscience innovates synthetic biology, designing superior medicines using living systems.

Seed · $17.3M26
Twist BioscienceTwist BioscienceSan Francisco, CA, USSynthetic DNAest. 2013Twist BioscienceSan Francisco, CA, US · est. 2013

Twist Bioscience: A leading US biotech firm specializing in synthetic DNA for diverse applications.

Public · $553.1M989
BluumbioBluumbioSan Francisco, CA, USest. 2021BluumbioSan Francisco, CA, US · est. 2021

BluumBio: Creating eco-friendly enzymes to detoxify and restore ecosystems.

Angel · $125k4
Wild MicrobesWild MicrobesCambridge, MA, USSustainable Productsest. 2022Wild MicrobesCambridge, MA, US · est. 2022

Wild Microbes: Innovating sustainable products through advanced microbial technology.

Pre-Seed · $3.3M4
Cannalysis
Cannalysis
Series A$23.6M192015Santa Ana, CA, US
Co-Founder

Leadership at Cannalysis

Brian LannonBrian LannonBoard Member

Similar to Cannalysis

Canalyte LaboratoriesCanalyte LaboratoriesRiverside, CA, USLab Testingest. 2019Canalyte LaboratoriesRiverside, CA, US · est. 2019

Cannalyte Laboratories: Premier lab providing precise testing for the cannabis and hemp industries.

Seed · $1.8M7
Nova Analytic LabsNova Analytic LabsPortland, ME, USLaboratory Testingest. 2017Nova Analytic LabsPortland, ME, US · est. 2017

Nova Analytic Labs: A comprehensive lab specializing in cannabis science, medicine, and research.

Seed · $501k11
PureVita LabsPureVita LabsWest Warwick, RI, USCannabis Testingest. 2019PureVita LabsWest Warwick, RI, US · est. 2019

PureVita Labs: Ensuring safety and accuracy in legal cannabis products through advanced testing methods.

Angel · $2.7M7
Method Testing LaboratoriesMethod Testing LaboratoriesTampa, FL, USCannabis Testingest. 2019Method Testing LaboratoriesTampa, FL, US · est. 2019

MTL Labs: Streamlining cannabis business with customer-centric, innovative testing solutions.

Seed · $2.5M28

Tyler Autera's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Tyler Autera

Usama FayyadUsama FayyadBoard Member · AudienceScienceMehul ShahMehul ShahCo-Founder · MertadoTy TylerTy TylerFounder · TerressentiaBlue ThomasBlue ThomasCo-Founder · BellhopAlex RandAlex RandFounder · Nextera Robotics